Investigational Antipsychotic Demonstrates Efficacy Without

Investigational agent KarXT is a first-in-class muscarinic receptor agonist demonstrating antipsychotic efficacy and safety in short- and long-term clinical trials.

Related Keywords

Ukraine , Russia , Italy , United States , Russian , Raymond Orton , Ronald Marcus , Invega Trinza , Samatha Yohn , Bristol Myers Squibb , Cenexel Hassman Research Institute , Schizophrenia International Research Society , Karuna Therapeutics , Psychiatric Times , New Drug Application , Bristol Myers , Annual Congress , Schizophrenia International Research ,